Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127911311 | 12791131 | 1 | I | 20120630 | 20160929 | 20160929 | EXP | US-ROCHE-1083392 | ROCHE | 0.00 | E | F | Y | 62.50000 | KG | 20160929 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127911311 | 12791131 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 10 MG/KG, CYCLE 28 DAYS | N | 125085 | 1372 | MG | SOLUTION FOR INFUSION | ||||||
| 127911311 | 12791131 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 10MG/KG, CYCLE 28 DAYS | N | 125085 | 1462 | MG | SOLUTION FOR INFUSION | ||||||
| 127911311 | 12791131 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 10MG/KG, CYCLE 28 DAYS | N | 125085 | 1364 | MG | SOLUTION FOR INFUSION | ||||||
| 127911311 | 12791131 | 4 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 10MG/KG, CYCLE 28 DAYS | N | 125085 | 1328 | MG | SOLUTION FOR INFUSION | ||||||
| 127911311 | 12791131 | 5 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 10 MG/KG, CYCLE 28 DAYS | N | 125085 | 1340 | MG | SOLUTION FOR INFUSION | ||||||
| 127911311 | 12791131 | 6 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 10 MG/KG, CYCLE 28 DAYS | N | 125085 | 665 | MG | SOLUTION FOR INFUSION | ||||||
| 127911311 | 12791131 | 7 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 10 MG/KG, CYCLE 28 DAYS | N | 125085 | 645 | MG | SOLUTION FOR INFUSION | ||||||
| 127911311 | 12791131 | 8 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 10 MG/KG, CYCLE 28 DAYS | N | 125085 | 1324 | MG | SOLUTION FOR INFUSION | ||||||
| 127911311 | 12791131 | 9 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 10 MG/KG, CYCLE 28 DAYS | N | 125085 | 1280 | MG | SOLUTION FOR INFUSION | ||||||
| 127911311 | 12791131 | 10 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 10 MG/KG, CYCLE 28 DAYS | N | 125085 | 1827 | MG | SOLUTION FOR INFUSION | ||||||
| 127911311 | 12791131 | 11 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 10 MG/KG, CYCLE 28 DAYS | N | 125085 | 1210 | MG | SOLUTION FOR INFUSION | ||||||
| 127911311 | 12791131 | 12 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 10 MG/KG, CYCLE 28 DAYS | N | 125085 | 621 | MG | SOLUTION FOR INFUSION | ||||||
| 127911311 | 12791131 | 13 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 10 MG/KG, CYCLE 28 DAYS | N | 125085 | 1226 | MG | SOLUTION FOR INFUSION | ||||||
| 127911311 | 12791131 | 14 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | CYCLE 28 DAYS | N | 0 | 50 | MG | |||||||
| 127911311 | 12791131 | 15 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | ALSO RECEIVED ON 18/APR/2011, | N | 0 | 80 | MG | |||||||
| 127911311 | 12791131 | 16 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | ALSO RECEIVED ON 13/JUN/2011, | N | 0 | 45 | MG | |||||||
| 127911311 | 12791131 | 17 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | N | 0 | 30 | MG | ||||||||
| 127911311 | 12791131 | 18 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | N | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127911311 | 12791131 | 1 | Pancreatic neoplasm |
| 127911311 | 12791131 | 14 | Pancreatic neoplasm |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127911311 | 12791131 | HO |
| 127911311 | 12791131 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127911311 | 12791131 | Acute kidney injury | |
| 127911311 | 12791131 | Blood bilirubin increased | |
| 127911311 | 12791131 | Blood creatinine increased | |
| 127911311 | 12791131 | Hypokalaemia | |
| 127911311 | 12791131 | Hypophosphataemia | |
| 127911311 | 12791131 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127911311 | 12791131 | 1 | 20110221 | 0 | ||
| 127911311 | 12791131 | 2 | 20110321 | 0 | ||
| 127911311 | 12791131 | 3 | 20110418 | 0 | ||
| 127911311 | 12791131 | 4 | 20110516 | 0 | ||
| 127911311 | 12791131 | 5 | 20110613 | 0 | ||
| 127911311 | 12791131 | 6 | 20110718 | 0 | ||
| 127911311 | 12791131 | 7 | 20110815 | 0 | ||
| 127911311 | 12791131 | 8 | 20110907 | 0 | ||
| 127911311 | 12791131 | 9 | 20111005 | 0 | ||
| 127911311 | 12791131 | 10 | 20111102 | 0 | ||
| 127911311 | 12791131 | 11 | 20111130 | 0 | ||
| 127911311 | 12791131 | 12 | 20111228 | 0 | ||
| 127911311 | 12791131 | 13 | 20120208 | 0 | ||
| 127911311 | 12791131 | 14 | 20110221 | 0 | ||
| 127911311 | 12791131 | 15 | 20110321 | 0 | ||
| 127911311 | 12791131 | 16 | 20110516 | 0 | ||
| 127911311 | 12791131 | 17 | 20110718 | 0 | ||
| 127911311 | 12791131 | 18 | 20110815 | 0 |